Laymen’s summary:
This study compared metabolite profiles in patients who switched from clozapine to other antipsychotic drugs with those who continued clozapine treatment. They found that patients who switched had lower levels of a clozapine metabolite involved in detoxification, indicating a potential link to clozapine tolerability. However, larger studies are needed to establish causality and understand the implications of these findings.
Access the publication here.